New Key Statistics Module, Z-Score and F-Score
OTCPK:FRTX Key Ratios
| Market Cap $ M | 5.50 |
| Enterprise Value $ M | -3.49 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.55 |
| Price/Sales | 0.68 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 8.00 |
| EPS (TTM) $ | -1.41 |
| Beneish M-Score | -4.26 |
| 10-y EBITDA Growth Rate % | 43.60 |
| 5-y EBITDA Growth Rate % | 68.00 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.61 |
| EV-to-EBITDA | 0.62 |
| PEG | -- |
| Shares Outstanding M | 5.97 |
| Net Margin (%) | -71.12 |
| Operating Margin % | -79.44 |
| Pre-tax Margin (%) | -71.12 |
| Quick Ratio | 6.98 |
| Current Ratio | 6.98 |
| ROA % (ttm) | -50.19 |
| ROE % (ttm) | -61.98 |
| ROIC % (ttm) | -606.52 |
| Dividend Yield % | -- |
| Altman Z-Score | -18.74 |
FRTX Number of Guru Trades
FRTX Volume of Guru Trades
Gurus Latest Trades with OTCPK:FRTX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:FRTX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Fresh Tracks Therapeutics Inc Insider Transactions
No Available Data
News about OTCPK:FRTX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers